Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

LTS LOHMANN Therapie-Systeme celebrates 25th anniversary

LTS LOHMANN Therapie-Systeme AG, the leading developer and manufacturer of transdermal, topical and oral systems with facilities in Andernach, Germany and West Caldwell, New Jersey, celebrates its 25th anniversary.

1 Sep 2009

Clinical Healthcare Enterprise Framework to help healthcare HR for effective talent management

Salary.com, Inc. (NASDAQ: SLRY), a leading provider of on-demand compensation, payroll and talent management solutions, announced today that it has added the Clinical Healthcare Enterprise Framework to its growing Job Model and Competency Library of more than 1,200 job models and 1,300 functional competencies, which provide data and structure for typical jobs at all levels of an organization. The framework will enable healthcare HR professionals to create job roles easily, deliver job models quickly, and power their talent management systems.

1 Sep 2009

New Vice President for Bioanalytical Development lab appointed by Cytovance Biologics

Cytovance Biologics LLC, a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian cell culture, today announced the addition of Dr. Jeffrey Su as Vice President of Bioanalytical Development to its diverse and growing scientific staff. Dr. Su will head up the state of the art Bioanalytical Development laboratory supporting existing and new client needs.

1 Sep 2009

Stanford University starts recruiting participants for swine flu vaccine clinical trial

The Stanford University School of Medicine is recruiting participants for a clinical trial to determine the safety of an experimental vaccine against the new H1N1 strain of influenza when the vaccine is combined with an immune-stimulating substance called an adjuvant. The trial will also examine whether use of the adjuvant improves the immune response to the vaccine.

31 Aug 2009

Merck undergoes restructuring after Schering-Plough merger

Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.

31 Aug 2009

BrainStorm Cell Therapeutics partners with Protein Production to start production of clinical-grade stem cell therapeutic product

BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that it has entered into an agreement with Protein Production Services Ltd. (PPS), a leading manufacturing contractor, in order to start Good Manufacturing Practice (cGMP) production of its stem cell therapeutic product.

31 Aug 2009

BloodStor biopreservation media product platform for cord blood banking industry

BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced the launch of its BloodStor biopreservation media product platform.

31 Aug 2009

Ranaz Corporation to raise funds through private placement

Ranaz Corporation ("Ranaz") (TSXV: RNZ), a company specialized in the manufacturing and marketing of protein and dietary supplements, announces that it intends to raise $675,000 through a non-brokered private placement of units.

29 Aug 2009

Ranaz reports second quarter 2009 financial results

Ranaz Corporation ("Ranaz"), a company specialized in the manufacturing and marketing of protein and dietary supplements, reported its results today for the second quarter ended June 30, 2009.

29 Aug 2009

Covalon Technologies announces fiscal 2009 third-quarter results

Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.

28 Aug 2009

Sinovac to supply its Anflu seasonal flu vaccine to the Beijing Public Health Bureau

Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Beijing Public Health Bureau has selected Sinovac as one of the four manufacturers to supply Anflu(R), Sinovac's seasonal influenza vaccine, for the benefit of the citizens of Beijing. The Beijing Public Health Bureau completed the bidding process for the purchase of flu vaccines and corresponding services for 2009 on August 26, 2009. The agreement will be executed after the public notice period.

28 Aug 2009

Bavarian Nordic generates a revenue of DKK 33 million in the first half of 2009

In the first half of 2009 Bavarian Nordic generated revenue of DKK 33 million and recorded a loss before tax of DKK 188 million. As of 30 June 2009 the Group's net free liquidity was DKK 489 million.

28 Aug 2009

Kamada finalizes agreement for the distribution of its intravenous alpha-1 antitrypsin in the United States

Kamada (TASE:KMDA), a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has entered into an exclusive agreement with a large US specialty pharmaceutical distributor company for the distribution of its flagship product, intravenous alpha-1 antitrypsin (AAT-IV) in the United States.

28 Aug 2009

Copan Diagnostics to expand manufacturing operations at its Murrieta facility

Despite tough economic times, Copan is proud to announce the expansion of its US operations. Copan Diagnostics, Inc. is undertaking a new multimillion dollar investment project to bring plastic transfer pipet and additional medical device manufacturing operations to its facility in Murrieta, California.

28 Aug 2009

DURECT signs agreement with King Pharmaceuticals to supply two excipients for REMOXY

DURECT Corporation (Nasdaq: DRRX) today reported that it has signed an exclusive long term excipient supply agreement with respect to REMOXY(R) with King Pharmaceuticals, Inc. (NYSE: KG). This agreement stipulates the terms and conditions under which DURECT will supply to King, based on DURECT's manufacturing cost plus a specified percentage mark-up, two key excipients used in the manufacture of REMOXY.

27 Aug 2009

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

Geron Corporation today provided additional comments on the recent clinical hold on its Spinal Cord Injury IND.

27 Aug 2009

Affymetrix and Beckman Coulter forge alliance to provide optimized genomic research solutions

Affymetrix, Inc. (Nasdaq: AFFX) and Beckman Coulter, Inc. today announced that they have entered into an agreement to offer researchers co-developed products from the market leaders in microarrays and automated liquid handlers.

From Beckman Coulter Life Sciences - Automation and Genomics 27 Aug 2009

California Bioscience Business Roundtable event hosted at the Quadrus Conference Center

Today a group of national and California-based partners hosted the California Bioscience Business Roundtable (BBR) event at the Quadrus Conference Center in Menlo Park. The event also featured Sam Youngman, the White Correspondent for The Hill newspaper, who provided a reporter's front row perspective on the unfolding health reform debate in Washington, D.C.

27 Aug 2009

Stemedica unveils two of its latest scientific discoveries at the 2009 World Stem Cell Summit

Stemedica Cell Technologies , Inc., ("Stemedica"), a world leader in stem cell research and manufacturing (a licensed manufacturer of clinical grade biological products as licensed by the State of California Food and Drug Branch) continues to advance the stem cell industry with the presentation of two of its latest scientific discoveries at the 2009 World Stem Cell Summit.

27 Aug 2009

Fluidigm manufactures more than 250 million microscopic NanoFlex valves at its Singapore biochip factory

Fluidigm today announced that its Singapore biochip factory has manufactured and shipped more than 250 million microscopic NanoFlex™ valves. The 250 million valves built into Fluidigm’s integrated fluidic circuits (IFCs) would be equivalent to the number of valves required for all the conventional plumbing – both residential and commercial – in a metropolitan region the size of the San Francisco Bay Area.

27 Aug 2009

Manufacturing News and Research

Further Reading

LTS LOHMANN Therapie-Systeme celebrates 25th anniversary

Clinical Healthcare Enterprise Framework to help healthcare HR for effective talent management

New Vice President for Bioanalytical Development lab appointed by Cytovance Biologics

Stanford University starts recruiting participants for swine flu vaccine clinical trial

Merck undergoes restructuring after Schering-Plough merger

BrainStorm Cell Therapeutics partners with Protein Production to start production of clinical-grade stem cell therapeutic product

BloodStor biopreservation media product platform for cord blood banking industry

Ranaz Corporation to raise funds through private placement

Ranaz reports second quarter 2009 financial results

Covalon Technologies announces fiscal 2009 third-quarter results

Sinovac to supply its Anflu seasonal flu vaccine to the Beijing Public Health Bureau

Bavarian Nordic generates a revenue of DKK 33 million in the first half of 2009

Kamada finalizes agreement for the distribution of its intravenous alpha-1 antitrypsin in the United States

Copan Diagnostics to expand manufacturing operations at its Murrieta facility

DURECT signs agreement with King Pharmaceuticals to supply two excipients for REMOXY

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

Affymetrix and Beckman Coulter forge alliance to provide optimized genomic research solutions

California Bioscience Business Roundtable event hosted at the Quadrus Conference Center

Stemedica unveils two of its latest scientific discoveries at the 2009 World Stem Cell Summit

Fluidigm manufactures more than 250 million microscopic NanoFlex valves at its Singapore biochip factory

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News